Discrepancies were resolved through discussion or adjudication by a third reviewer when consensus could not be reached
Neeraj Sharma, CEO & MD, OneSource Specialty Pharma Limited speaking on the development said "We are extremely excited to secure SFDA approval for semaglutide in Saudi Arabia, one of the largest GLP-1 market globally with significant long-term potential
Some evidence also suggests that GLP-1 RAs mitigate kidney function loss, especially in patients with evidence of kidney disease [12, 16], and this subject is being formally tested in the FLOW trial [17]
Revisit the case: WBUR reporter Ally Jarmanning dove into the nuances of this gruesome national network in "Last Seen: Postmortem." Listen to the full podcast here
Impact of fat on PCOS Fats and oils both provide lipids, which include fats and oils
However, the protective effect was strongest in patients with obesity and absent in non-obese patients, strongly suggesting that benefits are heavily confounded by weight loss and metabolic improvement rather than direct gut anti-inflammation (101)